EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA
- Authors: de Vos M.1, Ley S.1, Derendinger B.1, Dippenaar A.1, Grobbelaar M.1, Reuter A.2, Daniels J.2, Burns S.3, Theron G.1, Posey J.3, Warren R.1, Cox H.4
-
Affiliations:
- DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
- Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape Town
- Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
- Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town
- Issue: Vol 8, No 4 (2018)
- Pages: 566
- Section: TUBERCULOSIS AND MYCOBACTERIA: MOLECULAR APPROACH
- URL: https://ogarev-online.ru/2220-7619/article/view/119197
- DOI: https://doi.org/10.15789/2220-7619-2018-4-6.11
- ID: 119197
Cite item
Full Text
Abstract
About the authors
M. de Vos
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch University
Author for correspondence.
South Africa
S. Ley
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
B. Derendinger
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
A. Dippenaar
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
M. Grobbelaar
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
A. Reuter
Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape TownSouth Africa
J. Daniels
Médecins Sans Frontières, Operational Centre Brussels (OCB), Khayelitsha Project, Cape TownSouth Africa
S. Burns
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States
G. Theron
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
J. Posey
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GeorgiaUnited States
R. Warren
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human, Faculty of Medicine and Health Science, Stellenbosch UniversitySouth Africa
H. Cox
Institute of Infectious Disease and Molecular Medicine and Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape TownSouth Africa
Supplementary files
